Allison Kaeding

The natural history of soy allergy

Jessica H. Savage, Allison Kaeding, Elizabeth C. Matsui et al. · Journal of Allergy and Clinical Immunology · 2010 · 218 citations · Full text

Food Allergy, Allergy, Allergy Medicine +9

BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

Susan Bal, Myo Htut, Omar Nadeem et al. · Blood · 2023 · 55 citations

Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia

Allison Kaeding, Sonali P. Barwe, Anilkumar Gopalakrishnapillai et al. · Blood Advances · 2021 · 39 citations · Full text

Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study

Susan Bal, Mehmet H. Kocoglu, Omar Nadeem et al. · Blood · 2022 · 39 citations

Efficacy and Safety with Extended Follow-up in a Phase 1 Study of BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Heavily Pretreated Relapsed/Refractory (RR) Multiple Myeloma (MM)

Susan Bal, Larry D. Anderson, Omar Nadeem et al. · Blood · 2024 · 20 citations